Anna Norweg, Brittany Hofferber, Cheongeun Oh, Michael Spinner, Kimberly Stavrolakes, Marykay Pavol, Angela DiMango, Victoria H Raveis, Charles G Murphy, John P Allegrante, David Buchholz, Alejandro Zarate, Naomi Simon
BACKGROUND: Although dyspnea is a primary symptom of chronic obstructive pulmonary disease (COPD), its treatment is suboptimal. In both COPD and acute anxiety, breathing patterns become dysregulated, contributing to abnormal CO2 , dyspnea, and inefficient recovery from breathing challenges. While pulmonary rehabilitation (PR) improves dyspnea, only 1-2% of patients access it. Individuals with anxiety who use PR have worse outcomes. METHODS: We present the protocol of a randomized controlled trial designed to determine the feasibility and acceptability of a new, four-week mind-body intervention that we developed, called "Capnography-Assisted Learned, Monitored (CALM) Breathing," as an adjunct to PR...
September 18, 2023: Contemporary Clinical Trials